DOP028: The resolution of fecal calprotectin configurations and their biological functions in gut inflammationECCO'25 Berlin
2025
DOP030: Mucosal deficiency of mitochondria-driven humoral immunity is linked to Crohn’s DiseaseECCO'25 Berlin
2025
DOP031: Anti-IL-7 receptor plus anti-IL12/23 combination induces complete histological normalization in chronic colitisECCO'25 Berlin
2025
DOP032: Extracellular vesicles from Bifidobacterium longum Subspecies infantis attenuate intestinal inflammation via macrophage polarizationECCO'25 Berlin
2025
DOP033: Pre-Clinical Development of SL-325, a High Affinity DR3 Blocking Antibody, for Durable Blockade of the DR3/TL1A Axis in Inflammatory Bowel DiseaseECCO'25 Berlin
2025
DOP034: Intestinal stem cell dysfunction is driven by loss of HMGCS2-mediated ketogenic response in Ulcerative colitis and represents a novel therapeutic targetECCO'25 Berlin
2025
DOP037: The V-Sync study: Validation of the synchronization of the ENEIDA and UR-CARE registryECCO'25 Berlin
2025
DOP039: Dietary methyl group donor intake alleviates the susceptibility to inflammatory bowel disease influenced by environmental pollution in a prospective cohort studyECCO'25 Berlin
2025
DOP040: Plant-based diets mitigate incidence, disease course and comorbidity of inflammatory bowel disease: evidence across eight European countriesECCO'25 Berlin
2025
DOP041: The association between fermentable dietary fibre intake and risk of developing Crohn’s Disease: Results from the GEM ProjectECCO'25 Berlin
2025
DOP042: Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´s diseaseECCO'25 Berlin
2025
DOP043: Clinical outcomes and predictive factors differ in acute severe ulcerative colitis for East Asian and Western patientsECCO'25 Berlin
2025